Bio-Works Technologies AB (BIOWKS) — Capital Reinvestment Ratio

Latest as of June 2021: 0.10x

Bio-Works Technologies AB (BIOWKS) has a Capital Reinvestment Ratio of 0.10x as of June 2021, meaning it reinvests 0% of its operating cash flow (Skr9.35 Million) in capital expenditures (Skr891.00K). Check how tangible is Bio-Works Technologies AB's equity to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.10x

Capex / Operating Cash Flow

Operating Cash Flow

Skr9.35 Million

SEK

Capital Expenditures

Skr891.00K

SEK

Data as of

Jun 2021

Most recent filing

Annual Capital Reinvestment Ratio for Bio-Works Technologies AB (None–None)

Year-by-year Capital Reinvestment Ratio for Bio-Works Technologies AB from None to None. See cash generation quality of Bio-Works Technologies AB to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow